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Abstract
Parkinson’s disease (PD) is caused by the selective loss of dopaminergic neurons in the substantia nigra (SN) and the
depletion of striatal dopamine (DA). Acupuncture, as an alternative therapy for PD, has beneficial effects in both PD patients
and PD animal models, although the underlying mechanisms therein remain uncertain. The present study investigated
whether acupuncture treatment affected dopamine neurotransmission in a PD mouse model using 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP). We found that acupuncture treatment at acupoint GB34 improved motor function with
accompanying dopaminergic neuron protection against MPTP but did not restore striatal dopamine depletion. Instead,
acupuncture treatment increased dopamine release that in turn, may lead to the enhancement of dopamine availability in
the synaptic cleft. Moreover, acupuncture treatment mitigated MPTP-induced abnormal postsynaptic changes, suggesting
that acupuncture treatment may increase postsynaptic dopamine neurotransmission and facilitate the normalization of
basal ganglia activity. These results suggest that the acupuncture-induced enhancement of synaptic dopamine availability
may play a critical role in motor function improvement against MPTP.
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Introduction
Dopaminergic system dysfunction is implicated in a wide variety
of neurological disorders, including Parkinson’s disease (PD). PD is
characterized by the selective loss of dopaminergic neurons in the
substantia nigra (SN) and a depletion of striatal dopamine (DA),
and dopamine depletion in PD leads to abnormal changes of basal
ganglia activity that in turn, result in an inability to control
voluntary movement [1]. Dopamine replacement therapies remain
the most effective clinical option for PD patients despite the
occasionally severe side effects [2].
Recent studies from several laboratories including ours have
shown that acupuncture has a beneficial effect in rodent models of
PD [3,4,5]. In both the 6-hydroxydopamine (6-OHDA) lesioned rat
and1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)lesioned
mouse, acupuncture has proven to be neuroprotective. We have
demonstrated that acupuncture rescues dopaminergic neurons by
increasing the expressions of trkB [5], cycolphilin A [3], and Akt [6]
and by decreasing the inflammation in the substantia nigra [7].
Acupuncture has also been shown to reduce the oxidative stress in
the substantia nigra and striatum [8,9]. However, the underlying
mechanisms of acupuncture on the improvement of motor
dysfunction in PD models are not well understood.
Given the critical role of dopamine and the importance in the
neuroplasticity of the impaired basal ganglia on regulating motor
function in PD, we hypothesized that acupuncture improves the
motor deficits by modulating dopaminergic neurotransmission in
the striatum, and thus ameliorating the abnormal postsynaptic
changes induced by dopamine depletion in mouse Parkinsonian
model. Thus, in the present study, we compared the effects of
acupuncture on the motor function and dopaminergic neuron
survival with sham acupuncture (the same acupuncture stimula-
tion was given to a control point) in mouse Parkinsonian model.
The changes in the expressions of the phosphorylated DARPP-32
and FosB as well as the dopamine contents, dopamine efflux, and
turnover ratios were measured to investigate the role of
acupuncture against the changes induced by dopamine depletion
in the striatum.
Materials and Methods
Animals and MPTP intoxication
All experiments were approved by the Kyung Hee University
Animal Care Committee for animal welfare [KHUASP(SE)-09-
046] and were maintained in strict accordance with Guidelines of
the NIH and Korean Academy of Medical Sciences. Twelve-
week-old male C57BL/6 mice (Central Lab. Animal Inc., Seoul,
Republic of Korea), weighing 23–26 g each, were used in all of the
experiments. The mice were divided into Control, MPTP (MPTP
only), MPTP with acupuncture treatment at acupoint GB34
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point (MPTP+CP) groups. The mice in all of the MPTP groups
(MPTP, MPTP+AP, and MPTP+CP groups) received an
intraperitoneal injection of MPTP-HCl (30 mg/kg of free base;
Sigma-Aldrich, St. Louis, MO, USA) in saline at 24-h intervals for
five consecutive days. The mice in the Control group were injected
with saline instead of MPTP (Fig. 1B).
Acupuncture treatment
Two hours after each MPTP injection, acupuncture stimulation
was performed at an acupoint GB34 (MPTP+AP group) or at a
control point (MPTP+CP group) (Fig. 1A). After the final MPTP
injection, acupuncture stimulation continued daily for seven days
(total 12 days). In order to rule out the non-specific effects of
acupuncture, we used the sham acupuncture group in which the
same acupuncture stimulation was given to the control point.
Acupoint GB34 has been used to treat movement disorders in
traditional East Asian medicine [10], and also studied on the
relation with motor function in recent neuroimaging studies
[11,12]. Since we previously found that acupoint GB34 exerted
the highest neuroprotective effect among several candidate
acupoints (GB34, SI3, BL62, and ST36) using the same MPTP
protocol [3], GB34 was chosen for the present study. It is located
at the point of the intersection of lines from the anterior border to
the head of the fibula [13,14]. The control point was set at a point
that was approximately 3 mm to the lateral side of the tail on the
gluteus muscle (Fig. 1C, D). The mice were lightly immobilised to
minimize the restraint stress. Acupuncture needles (15 mm in
length, 0.20 mm in diameter; Haeng-lim-seo-weon Acuneedle
Co., Seoul, Republic of Korea) were bilaterally inserted to a depth
of 3 mm at GB34 or the control point, turned at a rate of two spins
per second for 15 seconds, and then immediately removed. All
mice in all groups were also gently immobilized by holding their
necks with the head in an upright position for 15 seconds, to give
the same immobilization stress as the acupuncture group.
Behavioural test
A rotarod instrument (MED associates Inc., St. Albans, VT,
USA) was used to simultaneously record the latency to fall of five
mice. The overall rod performance (ORP) method was used, as
previously described [15]. On day seven after the last MPTP or
saline injection, the mice were pre-trained three times with 1-h
intervals on an accelerating rod speed mode. The time on the
rod was recorded with a maximum of 240 seconds for successive
rotational speeds (16, 20, 24, 28, and 32 rpm), and the ORP
score was calculated by the trapezoidal method [16]. All
assessors were blinded to the expected results and experimental
groups.
Figure 1. Acupuncture treatment and experimental procedure. (A) The point location of acupuncture treatment (red circle). ‘AP (GB34)’ refers
to acupoint GB34. ‘CP’ (control point) refers to control point. (B) Experimental schedule. Mice in the MPTP, MPTP+AP, and MPTP+CP groups were
treated with 30 mg/kg of MPTP for five consecutive days, unless Control group were treated with saline instead of MPTP. Acupuncture treatment was
performed at acupoint GB34 (MPTP+AP) or a control point (MPTP+CP) once a day for 12 consecutive days after the first MPTP administration. (C, D)
Photographs of acupuncture treatment at GB34 (C) and control point (D). The mice were immobilised by holding their neck. Acupuncture needles
were inserted, turned at a rate of two spins per second for 15 seconds, and then immediately removed.
doi:10.1371/journal.pone.0027566.g001
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On day seven after the last MPTP or saline injection, the mice
were transcardially perfused with 4% paraformaldehyde in a
0.2 M phosphate buffer. Free-floating sections encompassing the
entire midbrain and striatum (40 mm thickness). Tissues, which are
between AP 23.08,23.28 mm from bregma for midbrain and
between AP +0.38,+0.98 mm from bregma for striatum in
accordance with the atlas of the mouse brain [17], were selected
for analysis. The selected tissues were removed, fixed, and
cryoprotected. An immunohistochemistry method was performed,
as previously described [18,19]. After incubation with 3% H2O2 in
a 0.05 M phosphate-buffered saline, the sections were blocked
with 1% BSA and normal goat serum. The sections were
incubated overnight at room temperature in primary antibodies:
rabbit tyrosine hydroxylase (TH, 1:1,000; Santa Cruz Biotechnol-
ogy, Santa Cruz, CA, USA), dopamine transporter (DAT, 1:500;
Millipore Co., Billerica, MA, USA), Thr-34-phospho-DARPP-32
(1:500; Abcam Inc., Cambridge, MA, USA), and FosB (1:500; Cell
Signalling Technology, Danvers, MA, USA). The tissue sections
were incubated with biotinylated anti-rabbit IgG (Vector Labo-
ratories, Inc., Burlingame, CA, USA) for 1 h at room temperature,
incubated with ABC reagent (Vector Laboratories Inc., Burlin-
game, CA, USA) for 1 h at room temperature, and incubated for
2 min in 0.02% diaminobenzidine and 0.003% hydrogen peroxide
in 1 M Tris-buffered saline (pH 7.5). After the reaction, the tissue
sections were mounted on gelatin-coated slides, dried, dehydrated,
and covered. For Nissl double staining, 0.5% Cresyl violet solution
was used for 5 min before mounting.
Image analysis
For stereological analysis of dopaminergic neuron cell counting,
TH- and Nissl-positive cells in the substantia nigra pars compacta
(SNpc) were counted bilaterally in five continuous 40 mm thickness
immunostained mesencephalic sections at the level between AP
23.08,23.28 mm from bregma (accordance with atlas of the
mice brain) using a Zeiss Axioscope 2 (Zeiss, Jena, Germany) and
an attached StereoInvestigator system (MicroBrightfield, VT,
USA). Stereological methods were used to analyze total volume
of the SNpc using optical fractionator (StereoInvestigator system;
MicroBrightfield, VT, USA). After counting, the SNpc nuclei were
reconstructed serially and their volume calculated with Stereo-
Investigator software. The optical fractionator stereological probe
was used to determine neuronal count in the SNpc in sections
stained for both Nissl and TH. For dopaminergic fiber analysis,
pictures of the striatum were taken using a bright-field microscope
(BX51; Olympus, Tokyo, Japan). Immunoreactive optical densities
were calculated using Image Pro software (version 6.0 for
Windows; Media Cybernetics Inc., Bethesda, MD, USA). To
correct for background differences, the optical density of the
corpus callosum of each brain tissue was selected and used for
normalization. p-DARPP-32 and FosB counts were performed by
sampling a 500 mm wide by 350 mm high area where 1 mm
distant from the vertical center of the brain and under the corpus
callosum.
In vivo microdialysis
The mice were anaesthetised with an anaesthetic solution
containing tiletamine/zolazepam 30 mg/kg (Zoletile; Virbac,
France) and xylazine 10 mg/kg (Rompun; Bayer, Korea). An
intracerebral guide cannula (MBR-5; BASi, USA) was stereotax-
ically implanted into the striatum (AP +0.1; ML +0.2; DV 20.2
from bregma), and coordinates are in accordance with atlas of the
mice brain. Acrylic cement (GC Corporation) was used for fixation
of the guide cannulas. Then the mice were placed individual home
cage 24 h for recovery from surgery. On the day of the
experiment, a microdialysis probe (MBR-2–5, 0.24 mm diameter,
2 mm membrane length, cut-off 38 KDa; BASi, USA) was
inserted through the guide cannula. The probes were connected
to a microinjection syringe pump (CMA/Microdialysis) and
filtered Ringer’s solution (145 mM NaCl, 3 mM KCl, 1 mM
MgCl2, 1.2 mM CaCl2, pH 7.4) perfused the probes at a flow rate
of 1 ml/min. After insertion of the probes, samples were collected
during 20-min throughout the experimental period. And total 220-
min samples were collected. The experiment was performed under
normal light conditions in an undisturbed room. The dialysates
were stored at 280uC until DA determination with high-
performance liquid chromatography (HPLC).
High performance liquid chromatography (HPLC)
analysis
The tissue contents of the neurotransmitters were measured
using HPLC (Waters Co., Milford, MA, USA) in combination
with an electrochemical detecting system (ESA Coulochem III
detection system, range 100 nA, potential 2100 mV to +320 mV;
ESA Inc., Chelmsford, MA, USA). Mice were sacrificed on day
seven after the last MPTP or saline injection, and the striatum of
each mouse was rapidly dissected, frozen in liquid nitrogen, and
stored at 272uC until assayed. These brain striatum tissues were
homogenized in 300 ml of 0.1% perchloric acid. The resultant
homogenates were centrifuged for 20 minutes at 10006ga t4 uC.
The supernatant was filtered through a 0.22 mm membrane, and
an aliquot (15 ml in volume) of the resulting solution was injected
into the HPLC pump. Chromatographic separation was per-
formed using a C18 reverse-phase column (150 mm63.9 mm,
4 mm; Waters Co., Milford, MA, USA), and data analyses were
performed using computer software (Empower; Waters Co.,
Milford, MA, USA). The mobile phase, which had a pH of 3.2,
consisted of 150 mM sodium phosphate monobasic monohydrate,
1.85 mM octanesulfonic acid, 0.05 mM EDTA, 0.01% triethyl-
amine, 4% methanol, and 6% acetonitrile. DA, 3,4, dihydrox-
yphenylacetic acid (DOPAC), homovanillic acid (HVA), and
serotonin standards were prepared in 0.1% perchloric acid
(Sigma-Aldrich, St. Louis, MO, USA). Each concentration was
adjusted with respect to the standard and quantified from a
standard curve. The levels of DA, DOPAC, HVA, and serotonin
were calculated as nanograms per microgram of total protein.
Data analysis
All procedures, assessments, and analyses were performed in a
blinded manner to minimise the observer bias. The SPSS, version
17.0 (SPSS Inc., Chicago, IL, USA), was used for statistical
procedures. All data are expressed as the mean 6 SEM. A
statistical analysis was performed using one-way ANOVA followed
by a post-hoc Newman-Keuls test. The effect of acupuncture
stimulation on dopamine efflux was determined by two-way
ANOVA analysis with repeated measures over time followed by
Bonferroni’s post-hoc test. In all of the analyses, differences were
considered to be statistically significant at P,0.05.
Results
Acupuncture treatment at GB34 improved motor
function and prevented dopaminergic neuron
degeneration against MPTP
Previously, we reported that GB34 exerted the highest neuropro-
tective effect among several candidate acupoints in a mice
Parkinsonian model [3,8]. In this study, we first examined whether
Dopamine Availability and Acupuncture
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MPTP. Acupuncture treatment was performed at GB34 (MPTP+AP
group) or the control point (MPTP+CP group) once a day for 12
consecutive days after the first MPTP administration (Fig. 1).
Acupuncture treatment at GB34 induced a significant improvement
of motor function against MPTP, whereas acupuncture treatment at
the control point had no effect. Mice in the MPTP group showed
significantly lower overall rod performance (ORP) scores
(4901.36501.9) in comparison to mice in the Control group
(6347.76272.2, P,0.05). Mice in the MPTP+AP group showed
significantly higher ORP scores (6148.76178.0) in comparison to
mice in the MPTP group (P,0.05). The ORP scores were not
statistically different between the MPTP and MPTP+CP groups
(5217.76251.6, Fig. 2E).
Also, a significant recovery of TH-positive cell numbers in the
MPTP+AP group was observed. The MPTP group had significantly
fewer TH-positive neurons in the SN (2536.836626.06) in comparison
to those observed in the Control group (5309.906461.48, P,0.01);
however, the MPTP+AP group had significantly more TH-positive
neurons in the SN (4233.346405.72) in comparison to those observed
in the MPTP group (P,0.05). There was no statistical difference
between the MPTP and the MPTP+CP groups (2140.076543.33,
Figs. 2A, B, D). To further support TH-positive cell count result, we
also performed Nissl-positive cell counts (supplementary figure S2).
Consistent with TH-positive cell counts, MPTP caused a considerable
loss of Nissl-positive cells in the substantia nigra pars compacta (SNc),
while acupuncture treatment led to a significant recovery of Nissl-
positive cell numbers in the SNc against MPTP. In the striatum,
acupuncture treatment also showed similar protection of dopaminergic
fibers against MPTP toxicity (65.6162.85% vs. 90.1462.47% of
Control group, P,0.001, Figs. 2C, F). These results demonstrate that
acupuncture treatment at a specific acupoint (GB34), but not at a
control point, significantly alleviated MPTP-induced motor dysfunc-
tion and dopaminergic neuron degeneration.
Since all of our above results display that acupuncture on
control point did not produce any effects, we did not use the
MPTP+CP group in the following experiments to minimize the
number of animals.
Figure 2. The behavioural and neuroprotective effects of acupuncture treatment at GB34 in MPTP mice. (A, B) Immunohistochemical
staining for TH-positive and Nissl-positive dopaminergic neurons in the substantia nigra in a low magnification (A, scale bar: 300 mm) and in a higher
magnification (B, scale bar: 100 mm). (C) Immunohistochemical staining for TH-positive dopaminergic fibers in the striatum. (Scale bar: 500 mm.)
(D) Bar graph of TH-positive cell counts in the substantia nigra of each group. (E) Bar graph of the overall rod performance (ORP) scores of each
group. (F) Bar graph of optical density of TH-positive fibers in the striatum of each group (n=7–10 per group). A significant recovery of TH-positive
cell numbers and fibers in the MPTP+AP group was observed. Also, acupuncture treatment at GB34 significantly improved motor function against
MPTP. Data are normalized to the Control group. *P,0.05, **P,0.01 and ***P,0.001 versus Control group, #P,0.05 and ###P,0.001 versus MPTP
group via one-way ANOVA followed by a Newman-Keuls test.
doi:10.1371/journal.pone.0027566.g002
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turnover ratios in the striatum
To examine any possible effect of acupuncture treatment on the
dopaminergic system, the levels of striatal DA and its metabolites,
DOPAC and HVA, were measured using HPLC. In this analysis,
the levels of serotonin in the same brain were measured for
internal control. In Figure 3, HPLC analysis revealed that MPTP
administration induced a significant 80% depletion in striatal
dopamine levels in both the MPTP and MPTP+AP groups in
comparison to the Control group (95.7610.5 vs. 22.164.4 ng/mg
protein, P,0.001, Fig. 3A), whereas serotonin levels were not
statistically different among the groups (43.066.0 vs.
39.361.3 ng/mg protein, P.0.05, Fig. 3E). There were no
significant differences in striatal dopamine levels between the
MPTP and MPTP+AP groups (22.164.4 vs. 24.464.7 ng/mg
protein, Fig. 3A); however, there was a significant increase in HVA
in the MPTP+AP group in comparison to that observed in the
MPTP group (2.760.3 vs. 4.460.5 ng/mg protein, P,0.05,
Fig. 3A). Moreover, there were significant increases in dopamine
turnover ratios (DOPAC/DA, HVA/DA, and DOPAC+HVA/
DA) in the MPTP+AP group (25.363.5, 23.665.1, and 48.968.1)
in comparison to both the MPTP (14.761.2, P,0.01; 13.561.5
and 28.262.6, P,0.05 each) and Control groups (10.962.2,
7.560.5, and 18.462.3, P,0.01 each, Figs. 3B, C, D).
Since acupuncture treatment improved motor function (Fig. 2E)
but did not restore striatal dopamine level (Fig. 3A), we further
investigated whether acupuncture treatment modulates dopamine
release in the striatum. Using microdialysis-HPLC method,
extracellular dopamine levels in the striatum of Control, MPTP,
and MPTP+AP mice were measured after acupuncture stimula-
tion. We found that, only in the striatum of MPTP+AP mice,
acupuncture stimulation significantly increased dopamine efflux at
time point 20 min (P,0.001). Dopamine efflux was six-fold higher
in MPTP+AP group than in MPTP group (P,0.001, Fig. 4).
However, dopamine efflux was not altered both in the striatum of
Control and MPTP mice at all time points. These results indicate
that acupuncture treatment at GB34 did not restore the MPTP-
induced depletion of total striatal dopamine but significantly
increased dopamine release in the striatum, which may result in
improvement of motor fun‘ction in this model of PD.
Acupuncture treatment at GB34 mitigated MPTP-
induced increases in the phosphorylation of DARPP-32
and the expression of FosB
Striatal dopamine depletion causes compensatory changes in
postsynaptic medium spiny neurons through the hyperactivation
of 39-59-cyclic adenosine monophosphate (cAMP) signalling [20],
which is mediated by dopamine- and cAMP-regulated phospho-
Figure 3. Tissue dopamine contents and its turnover ratios in
the striatum of each group. (A) Contents of dopamine and its
metabolates, DOPAC and HVA, in the striatum of each group (n=8 per
group). (B) DOPAC/DA, (C) HVA/DA, and (D) (DOPAC plus HVA)/DA
turnover ratio of each group (n=8 per group). (E) Serotonin levels of
each group (n=8 per group). MPTP administration induced a significant
decrease in the dopamine and its metabolates levels, whereas
acupuncture treatment at GB34 significantly increased the dopamine
turnover ratio. **P,0.01 and ***P,0.001 compared to Control,
#P,0.05 and ##P,0.01 compared to MPTP group, one-way ANOVA,
followed by Newman-Keuls test.
doi:10.1371/journal.pone.0027566.g003
Figure 4. Time courses of dopamine (DA) efflux levels in the
striatum. Data presented are mean 6 SEM. On the day of the
behavioral test (on day 12 after the first saline (Control group) or MPTP
(MPTP group and MPTP+AP group) injection), extracellular DA levels in
the striatum of Control, MPTP, and MPTP+AP mice were measured after
a single acupuncture stimulation using microdialysis-HPLC method.
Since MPTP+AP mice already received 11 day’s acupuncture treatment
before the final acupuncture stimulation, MPTP+AP mice received in
total 12 day’s acupuncture treatment, whereas Control and MPTP mice
received only a single acupuncture treatment. At 20 min after
acupuncture stimulation, only MPTP+AP group showed an increase in
dopamine efflux. The increase in dopamine efflux was returned to its
basal level at 120 min after acupuncture stimulation. Data are
normalized to the baseline data of each group. The effect of
acupuncture stimulation on dopamine efflux was determined by two-
way ANOVA analysis with repeated measures over time followed by
Bonferroni’s post-hoc test. *** P,0.001 versus Control group and
### P,0.001 versus MPTP group.
doi:10.1371/journal.pone.0027566.g004
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MPTP-induced postsynaptic changes using immunohistochemical
staining for phospho-DARPP-32 at Thr34. MPTP administration
induced a significant increase in the phosphorylation of DARPP-
32 at Thr34 in the MPTP group (162.7616.5% of Control group)
in comparison to the Control group (100.0612.2% of Control
group, P,0.001). Acupuncture treatment at GB34 significantly
mitigated the increased phosphorylation of DARPP-32 at Thr34
in the MPTP+AP group (107.869.1% of Control group,
P,0.001, Figs. 5A, B).
In addition, we looked for another change in postsynaptic
markers of dopamine depletion in the striatum. Because MPTP
administration is known to upregulate expression of immediate
early gene, FosB [22,23,24], we also examined changes of FosB
expression in the striatum. Consistent with previous reports,
MPTP administration induced a significant increase in FosB
expression in the MPTP group (130.7611.2% of Control group)
in comparison to the Control group (100.064.1% of Control
group, P,0.05). Acupuncture treatment at GB34 significantly
reduced the MPTP-induced increase of FosB expression in the
MPTP+AP group (83.268.3% of Control group, P,0.001,
Figs. 6A, B). These results demonstrate that MPTP-induced
increases in the phosphorylation of DARPP-32 and the expression
of FosB were mitigated by acupuncture treatment at GB34,
suggesting that the acupuncture treatment may normalize MPTP-
induced abnormal postsynaptic changes.
Discussion
The present study demonstrates that acupuncture treatment
improved motor function against MPTP most likely through an
enhancement of dopamine availability in the synaptic cleft rather
than the restoration of the levels of total striatal dopamine.
We found that only acupuncture treatment at GB34, but not at
control point significantly improved motor function and prevented
dopaminergic neuron degeneration against MPTP (Fig. 2),
suggesting that the stimulating a specific point is important to
produce the benefits of acupuncture. We also found that
acupuncture treatment at GB34 alleviated MPTP-induced motor
dysfunction and dopaminergic neuron degeneration, and in-
creased dopamine turnover ratios but did not restore the levels of
total striatal dopamine (Figs. 2, 3). It has been suggested that
increases in DOPAC/DA and HVA/DA ratios in the striatum
reflect an increased metabolism and release of dopamine [25].
Therefore, the observed increases in relative HVA concentrations
and increases in DOPAC/DA and HVA/DA ratios following
acupuncture treatment in MPTP-intoxicated mice (Fig. 3) suggest
that acupuncture may induce an increased rate of dopamine
metabolism in the protected dopaminergic neurons with an
accompanying increase in dopamine release from dopaminergic
terminals. Indeed, we found that acupuncture stimulation
significantly increased dopamine release only in MPTP+AP
group, but not in Control and MPTP groups (Fig. 4). Some
studies displayed that MPTP administration increased the
dopamine turnover ratio as a compensatory mechanism with the
impairment of motor function [26,27]. In our study, MPTP group
also showed mild increase of turnover ratios, but not statistically
different with the Control group. However, the animals with the
improvement of motor function after acupuncture enhanced
dopamine turnover ratios much more significantly than MPTP
group. Recently, we reported that acupuncture can restore
MPTP-induced impairment of phosphatidylinositol 3-kinase
(PI3K)/Akt cell survival pathway, and PI3K/Akt signalling
mediates both acupuncture-induced dopaminergic neuron protec-
tion and motor function improvement [6]. Given LY294002, a
specific inhibitor of PI3K, concomitantly blocked both acupunc-
ture-induced dopaminergic neuron protection and motor function
improvement [6], there seems to be a strong correlation between
acupuncture-induced neuroprotection and motor function im-
provement. Therefore, our previous [6] and the present (Figs. 2, 3,
4) results raise one possibility that the acupuncture-induced
Figure 5. Changes in the phosphorylation state of DARPP-32
by MPTP and acupuncture treatment at GB34. (A) Representative
images of immunohistochemical staining for phospho-DARPP-32 at
Thr34. (Scale bars: 100 mm.) The top-right panel shows a transverse
section of the striatum. The box represents the analysed area. (B) Bar
graph of striatal phospho-DARPP-32-positive signal counts (n=12 per
group). Data are normalized to the Control group. MPTP administration
induced a significant increase in the phosphorylation of DARPP-32 at
Thr34, whereas acupuncture treatment at GB34 significantly mitigated
the increased phosphorylation of DARPP-32 at Thr34. **P,0.01 versus
Control group and ##P,0.01 versus MPTP group via one-way ANOVA
followed by a Newman-Keuls test.
doi:10.1371/journal.pone.0027566.g005
Figure 6. Changes in the expression of FosB by MPTP and
acupuncture treatment at GB34. (A) Representative images of
immunohistochemical staining for FosB. (Scale bars: 100 mm.) The top-
right panel shows a transverse section of the striatum. The box
represents the analysed area. (B) Bar graph of striatal FosB-positive
nuclei counts (n=12 per group). Data are normalized to the Control
group. MPTP administration increased FosB expression, whereas
acupuncture treatment at GB34 reduced the MPTP-induced increase
of FosB expression. *P,0.05 versus Control group and ###P,0.001
versus MPTP group via one-way ANOVA followed by a Newman-Keuls
test.
doi:10.1371/journal.pone.0027566.g006
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dopamine efflux from the surviving dopaminergic neurons, which
in turn may result in improved motor function without
necessitating restoration of the striatal dopamine content. There
are several studies suggesting that the striatal dopamine content is
not necessarily correlated with the improvement of motor function
[28,29,30]. It is well known that dopamine transporter (DAT)
density also plays a role in dopamine transmission by modulating
dopamine reuptake. Thus, additionally, we performed the
immunohistochemical detection of DAT in the striatum to observe
the involvement of DAT. Intriguingly, we observed that there
were no significant differences in DAT expression levels between
MPTP and MPTP+AP groups (Supplementary Fig. S1), whereas
MPTP-induced reduction of TH expression in the adjacent
striatum was significantly restored after acupuncture treatment
(Fig. 2D), which might result in the increases in DOPAC/DA and
HVA/DA ratios in the striatum. However, whether the changes in
DAT density participate in the improvement of motor function
needs further investigation.
Taken together, our results suggest that acupuncture treatment
at GB34 ameliorates MPTP-induced motor dysfunction most
likely through an enhancement of dopamine availability in the
synaptic cleft rather than the restoration of the levels of total
striatal dopamine. Alternatively, the acupuncture-induced protec-
tion of dopaminergic neurons shown in our study may result in the
maintenance of the functional integrity of the SNr, thereby
compensating for striatal dopamine depletion. Because, there are
several showing that the substantia nigra pars compacta
dopaminergic neurons release dopamine not only from the striatal
terminal fibres but also from the dendrite network to the substantia
nigra pars reticulata (SNr) [31,32]. The basal ganglia output
structure also may participate in the improvement of motor
function induced by acupuncture as Jia et al. suggested [30,33].
However, to clarify the relationship between our results and above
hypothesis needs to be further exploration.
MPTP-induced striatal dopamine depletion induces postsynap-
tic abnormalities [22,34]. Therefore, if an acupuncture-induced
increase in synaptic dopamine availability (or dopamine neuro-
transmission) can compensate for the MPTP-induced depletion of
absolute dopamine levels in the synaptic cleft, a normalization of
MPTP-induced postsynaptic abnormalities may occur. Because
MPTP-induced postsynaptic changes are often measured by
changes in FosB expression [22,23,24] and FosB expression is
regulated by DARPP-32 signalling [20], we examined MPTP-
induced postsynaptic changes of phospho-DARPP-32 at Thr34
and FosB using immunohistochemistry. Consistent with previous
reports [22,23,24], MPTP intoxication increased FosB expression
in the striatum (Fig. 6). We also found an increase in the
phosphorylation of DARPP-32 after MPTP intoxication (Fig. 5).
Considering the report that 6-hydroxydopamine did not alter the
phosphorylation levels of DARPP-32 [35], our result suggests that
MPTP-induced DARPP-32 signalling may differ from 6-OHDA-
induced DARPP-32 signalling. More importantly, acupuncture
treatment significantly reduced MPTP-induced increases in the
phosphorylation of DARPP-32 and the expression of FosB (Figs. 5,
6). These results demonstrate that acupuncture treatment
mitigated MPTP-induced abnormal postsynaptic changes, sug-
gesting that acupuncture treatment may increase postsynaptic
dopamine neurotransmission and facilitate the normalization of
basal ganglia activity.
In conclusion, our results suggest that increased dopamine
release after acupuncture treatment at GB34 may lead to an
enhancement of dopamine availability in the synaptic cleft that in
turn, may play an essential role in motor function improvement
Figure 7. Schematic representation of the effect of acupuncture on dopamine availability and the concomitant postsynaptic
response. (A) Normal condition (Control group). (B) MPTP lesioning (MPTP group). (C) Acupuncture treatment at GB34 following MPTP lesioning
(MPTP+AP group). Striatal dopamine depletion caused by MPTP-induced dopaminergic denervation leads to abnormally high levels of Thr34-
phosphorylated DARPP-32 and the consequent upregulation of FosB in the striatum, which, in turn, may result in abnormal motor function (B).
Acupuncture treatment at GB34 following MPTP lesioning alleviated MPTP-induced denervation of dopaminergic neurons but did not restore the
levels of total striatal dopamine; however, acupuncture treatment increased dopamine availability likely through increased dopamine release, which,
in turn, may lead to the normalization of postsynaptic abnormalities. Therefore, we propose that acupuncture treatment at GB34 improved motor
function against MPTP most likely through an enhancement of dopamine availability in the synaptic cleft.
doi:10.1371/journal.pone.0027566.g007
Dopamine Availability and Acupuncture
PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 11 | e27566against MPTP (Fig. 7). From a clinical point of view, one of the
major issues in the treatment of PD is how to reduce the adverse
effects of L-DOPA. Indeed, various attempts have been made to
find a new clinical therapy that can decrease the adverse effects of
L-DOPA and increase its efficacy [36]. Our finding that
acupuncture improved motor function without necessitating
striatal dopamine refilling suggests that acupuncture treatment
can be complementary to dopamine replacement therapy.
Therefore, we expect that the elucidation of the underlying
mechanisms of acupuncture may contribute to the development of
novel clinical strategies for the treatment of PD.
Supporting Information
Figure S1 Dopamine transporter (DAT) expression in
the striatum of each group. Immunochemistry was per-
formed to detect DAT (1:1000, Millipore, USA) positive
dopaminergic fibers in the striatum. (A) Immunohistochemical
staining for DAT-positive dopaminergic fibers in the striatum.
(Scale bars: 500 mm.) (B) Bar graph of DAT-positive optical
density of fibers in the striatum of each group (n=7–10 per
group). MPTP group showed significant decrease in DAT
expression compared to Control, and MPTP+AP group did not
alter the decrease. Data are normalized to the Control group.
*** P,0.001 versus Control group via one-way ANOVA
followed by a Newman-Keuls test.
(DOC)
Figure S2 Nissl staining in the substantia nigra pars
compacta. For Nissl staining, the substantia nigra tissues were
stained with 0.5% cresyl violet, and unbiased stereological counts
were made. (A) Representative images of Nissl stained neurons in
the substantia nigra of each group. Red lines mark the boundaries
of the substantia nigra pars compacta (SNc). (B) Bar graph of
Nissl stained neuron counts in the SNc of each group (n=4 per
group). Consistent with TH-positive cell counts, a significant
recovery of Nissl-positive cell numbers in MPTP+AP group was
observed. Data are normalized to the Control group. *P,0.05
versus Control group, and #P,0.05 versus MPTP group via
one-way ANOVA followed by a Newman-Keuls test.
(DOC)
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